Laboratory Services – hLAB

hLAB is a specialist virology, immunology and molecular laboratory provider. Our comprehensive range of services are tailored to support drug/antiviral and vaccine research and development, driving innovation in the field of virology, together with our clients.

Visit hLAB

Our state-of-the-art facilities, based in Canary Wharf and opened in July 2024, include BSL 2 and 3 laboratories allowing our team to focus on specialised virology, immunology and molecular biology lab services providing high quality sample analysis and data outputs enabling our clients to develop proof of concepts, and to make breakthrough discoveries in the pathology and possible treatment of diseases.

Our work includes assay development, technology transfer and optimisation across immunology, molecular and cell-based assays, including offering extensive options in sample matrix and stability testing and analysis. All assays are validated to FDA, EMA and ICH guidelines.

Services:

Molecular Services

Utilise our advanced automated molecular workflows for precise target quantification or sensitive analysis.

Immunology Services

Specialized in analysing clinical trial samples to accurately quantify and characterize immune responses, advancing drug development with confidence.

Virology Services

Achieve precise, reliable results with our highly skilled team of virologists, driving impactful research and development.

Clinical (Field) Trial Logistics

Seamless, reliable logistics for your field trials, ensuring sample integrity from collection to analysis.

Our Biobank

Our research biobank accelerates healthcare innovation through collaborative access to high-quality clinical samples. Focused on vaccine development, immunology, virology, and respiratory disease research, our HTA-governed biobank adheres to strict ethical standards, safeguarding patient rights and privacy. With a diverse repository of human biofluids, we provide researchers with critical insights to drive breakthroughs and shape the future of healthcare.

hLAB in numbers

0+
samples processed
0+
biobank samples
0+
assays yearly

Our Accreditations

Good Clinical Practice (GCP) is an international ethical and scientific quality standard; for designing, conducting, recording and reporting trials. Ensuring participant safety prevails over the interests of science and society.

hVIVO is accredited by the Human Tissue Authority (HTA), meaning that we have been recognized by the HTA as compliant with standards and regulations for the ethical and legal removal, storage, and use of human tissue. A HTA license is essential, as hVIVO handles human tissue for various research purposes.

All clinical trials comply with GCP and/or GCP for Laboratories (GCLP) guidance. Human Challenge Agent-only clinical studies that do not involve IMP also comply with GCP/GCLP.

The CAP laboratory accreditation programme ultimately recognises laboratory quality and compliance. CAP accreditation is globally recognised, and provides assurance the hVIVO laboratory services are able to be deliver to a standard.

Interested in learning more about our laboratory services? Find out how hLAB can help you.

Visit hLAB
chevron-downarrow-up